Aviva »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Aviva

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Aviva from 13F filings

Historical chart of Aviva investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Aviva consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Aviva

Quarter filed Position value Share count Share price at filing
2023-12-31 $929k 1.0M 0.93
2023-09-30 $4.7M 5.0M 0.94

More positions owned by Aviva

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl (GOOGL)
UnitedHealth (UNH)
Alphabet Cap Stk Cl (GOOG)
Visa Com Cl A (V)
CRH Ord (CRH)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Home Depot (HD)
JPMorgan Chase & Co. (JPM)

View all positions for Aviva

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
Leucadia National Corporation
SSI Investment Management
CSS
Readystate Asset Management

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1